Abstract
Purpose
We evaluated whether preimplantation genetic testing for aneuploidy (PGT-A) could increase the cumulative live birth rate (CLBR) in patients with recurrent implantation failure (RIF) and recurrent pregnancy loss (RPL).
Methods
The clinical records of 7,668 patients who underwent oocyte retrieval (OR) with or without PGT-A were reviewed for 365 days and retrospectively analyzed. Using propensity score matching, 579 patients in the PGT-A group were matched one-to-one with 7,089 patients in the non-PGT-A (control) group. Their pregnancy and perinatal outcomes and CLBRs were statistically compared.
Results
The live birth rate per single vitrified-warmed blastocyst transfers (SVBTs) significantly improved in the PGT-A group in all age groups (P < 0.0002, all). Obstetric and perinatal outcomes were comparable between both groups regarding both RIF and RPL cases. Cox regression analysis demonstrated that in the RIF cases, the risk ratio per OR was significantly lower in the PGT-A group than in the control group (P = 0.0480), particularly in women aged < 40 years (P = 0.0364). However, the ratio was comparable between the groups in RPL cases. The risk ratio per treatment period was improved in the PGT-A group in both RIF and RPL cases only in women aged 40–42 years (P = 0.0234 and P = 0.0084, respectively).
Conclusion
Increased CLBR per treatment period was detected only in women aged 40–42 years in both RIF and RPL cases, suggesting that PGT-A is inappropriate to improve CLBR per treatment period in all RIF and RPL cases.
Similar content being viewed by others
Data availability
The primary data for this study are available from the authors on direct request.
Code availability
Not applicable.
References
Katagiri Y, Jwa SC, Kuwahara A, Iwasa T, Ono M, Kato K, Kishi H, Kuwabara Y, Harada M, Hamatani T, Osuga Y. Assisted reproductive technology in Japan: A summary report for 2020 by the ethics Committee of the Japan Society of obstetrics and gynecology. Reprod Med Biol. 2023;22:e12494.
Gleicher N, Orvieto R. Is the hypothesis of preimplantation genetic screening (PGS) still supportable? A review. J Ovarian Res. 2017;10:21.
Haviland MJ, Murphy LA, Modest AM, Fox MP, Wise LA, Nillni YI, Sakkas D, Hacker MR. Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design. Hum Reprod. 2020;35:2356–64.
Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, Treff NR, Scott RT Jr. In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril. 2013;100:100–7.
Scott RT Jr, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR. Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril. 2013;100:697–703.
Sanders KD, Silvestri G, Gordon T, Griffin DK. Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018. J Assist Reprod Genet. 2021;38:3277–85.
Bhatt SJ, Marchetto NM, Roy J, Morelli SS, McGovern PG. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study. Hum Reprod. 2021;36:2339–44.
Pantou A, Mitrakos A, Kokkali G, Petroutsou K, Tounta G, Lazaros L, Dimopoulos A, Sfakianoudis K, Pantos K, Koutsilieris M, Mavrou A, Kanavakis E, Tzetis M. The impact of preimplantation genetic testing for aneuploidies (PGT-A) on clinical outcomes in high risk patients. J Assist Reprod Genet. 2022;39:1341–9.
Kucherov A, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age </= 40: an analysis of 133,494 autologous cycles reported to SART CORS. J Assist Reprod Genet. 2023;40:137–49.
Mejia RB, Capper EA, Summers KM, Mancuso AC, Sparks AE, Van Voorhis BJ. Cumulative live birth rate in women aged </=37 years after in vitro fertilization with or without preimplantation genetic testing for aneuploidy: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System retrospective analysis. F S Rep. 2022;3:184–91.
Alteri A, Cermisoni GC, Pozzoni M, Gaeta G, Cavoretto PI, Vigano P. Obstetric, neonatal, and child health outcomes following embryo biopsy for preimplantation genetic testing. Hum Reprod Update. 2023;29:291–306.
Brookhart MA, Wyss R, Layton JB, Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6:604–11.
Glynn RJ, Schneeweiss S, Sturmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006;98:253–9.
Kato K, Kuroda T, Yamadera-Egawa R, Ezoe K, Aoyama N, Usami A, Miki T, Yamamoto T, Takeshita T. Preimplantation genetic testing for aneuploidy for recurrent pregnancy loss and recurrent implantation failure in minimal ovarian stimulation cycle for women aged 35–42 years: Live birth rate, developmental follow-up of children, and embryo ranking. Reprod Sci. 2023;30:974–83.
Iwasa T, Kuwahara A, Takeshita T, Taniguchi Y, Mikami M, Irahara M. Preimplantation genetic testing for aneuploidy and chromosomal structural rearrangement: A summary of a nationwide study by the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2023;22:e12518.
Sato T, Sugiura-Ogasawara M, Ozawa F, Yamamoto T, Kato T, Kurahashi H, Kuroda T, Aoyama N, Kato K, Kobayashi R, Fukuda A, Utsunomiya T, Kuwahara A, Saito H, Takeshita T, Irahara M. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure. Hum Reprod. 2019;34:2340–8.
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–11.
Eshre Guideline Group on RPL, Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, Nelen W, Peramo B, Quenby S, Vermeulen N, Goddijn M. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018: hoy004.
Ezoe K, Fukuda J, Takeshima K, Shinohara K, Kato K. Letrozole-induced endometrial preparation improved the pregnancy outcomes after frozen blastocyst transfer compared to the natural cycle: a retrospective cohort study. BMC Pregnancy Childbirth. 2022;22:824.
Karakida S, Ezoe K, Fukuda J, Yabuuchi A, Kobayashi T, Kato K. Effects of gonadotropin administration on clinical outcomes in clomiphene citrate-based minimal stimulation cycle IVF. Reprod Med Biol. 2020;19:128–34.
Kato K, Ezoe K, Yabuuchi A, Fukuda J, Kuroda T, Ueno S, Fujita H, Kobayashi T. Comparison of pregnancy outcomes following fresh and electively frozen single blastocyst transfer in natural cycle and clomiphene-stimulated IVF cycles. Hum Reprod Open. 2018;2018:hoy006.
Ezoe K, Coticchio G, Takenouchi H, Taoda S, Namerikawa S, Honda K, Miki T, Okimura T, Kobayashi T, Borini A, Kato K. Spatiotemporal perturbations of pronuclear breakdown preceding syngamy affect early human embryo development: a retrospective observational study. J Assist Reprod Genet. 2022;39:75–84.
Ezoe K, Miki T, Akaike H, Shimazaki K, Takahashi T, Tanimura Y, Amagai A, Sawado A, Mogi M, Kaneko S, Ueno S, Coticchio G, Cimadomo D, Borini A, Rienzi L, Kato K. Maternal age affects pronuclear and chromatin dynamics, morula compaction and cell polarity, and blastulation of human embryos. Hum Reprod. 2023;38:387–99.
Gardner D, Schoolcraft W. In Vitro Culture of Human Blastocyst. In: Jansen R, Mortimer D, editors. Towards Reproductive Certainty: Infertility and Genetics Beyond. Carnforth: Parthenon Pres; 1999. p. 377–88.
Kato K, Ueno S, Yabuuchi A, Uchiyama K, Okuno T, Kobayashi T, Segawa T, Teramoto S. Women’s age and embryo developmental speed accurately predict clinical pregnancy after single vitrified-warmed blastocyst transfer. Reprod Biomed Online. 2014;29:411–6.
Ueno S, Uchiyama K, Kuroda T, Okimura T, Yabuuchi A, Kobayashi T, Kato K. Establishment of day 7 blastocyst freezing criteria using blastocyst diameter for single vitrified-warmed blastocyst transfer from live birth outcomes: a single-center, large cohort, retrospectively matched study. J Assist Reprod Genet. 2020;37:2327–35.
Miki T, Ezoe K, Kouraba S, Ohata K, Kato K. Time from trophectoderm biopsy to vitrification affects the developmental competence of biopsied blastocysts. Reprod Med Biol. 2022;21:e12439.
Maggiulli R, Giancani A, Cimadomo D, Ubaldi FM, Rienzi L. Human blastocyst biopsy and vitrification. J Vis Exp. 2019;149. https://doi.org/10.3791/59625.
Kato K, Kuroda T, Yamadera-Egawa R, Ezoe K, Aoyama N, Usami A, Miki T, Yamamoto T, Takeshita T. Preimplantation genetic testing for aneuploidy for recurrent pregnancy loss and recurrent implantation failure in minimal ovarian stimulation cycle for women aged 35–42 years: live birth rate, developmental follow-up of children, and embryo ranking. Reprod Sci. 2022;30:974–83.
Onogi S, Ezoe K, Nishihara S, Fukuda J, Kobayashi T, Kato K. Endometrial thickness on the day of the LH surge: an effective predictor of pregnancy outcomes after modified natural cycle-frozen blastocyst transfer. Hum Reprod Open. 2020;2020:hoaa060.
Takeshima K, Ezoe K, Onogi S, Kawasaki N, Hayashi H, Kuroda T, Kato K. Endometrial preparation and maternal and obstetrical outcomes after frozen blastocyst transfer. AJOG Glob Rep. 2022;2:100081.
Ueno S, Ezoe K, Abe T, Yabuuchi A, Uchiyama K, Okuno T, Kobayashi T, Kato K. Maternal age and initial beta-hCG levels predict pregnancy outcome after single vitrified-warmed blastocyst transfer. J Assist Reprod Genet. 2014;31:1175–81.
Ezoe K, Hickman C, Miki T, Okimura T, Uchiyama K, Yabuuchi A, Kobayashi T, Coticchio G, Kato K. Cytoplasmic halo characteristics during fertilization and their implications for human preimplantation embryo development and pregnancy outcome. Reprod Biomed Online. 2020;41:191–202.
Onogi S, Ezoe K, Kawasaki N, Hayashi H, Kuroda T, Takeshima K, Tanoue K, Nishii S, Kato K. Maternal and obstetric outcomes are influenced by developmental stage and cryopreservation of transferred embryos after clomiphene citrate-based minimal stimulation IVF. Hum Reprod Open. 2022;2022:hoac018.
Jansen C, Kleinrouweler CE, Kastelein AW, Ruiter L, van Leeuwen E, Mol BW, Pajkrt E. Follow-up ultrasound in second-trimester low-positioned anterior and posterior placentae: prospective cohort study. Ultrasound Obstet Gynecol. 2020;56:725–31.
Itabashi K, Fujimura M, Kusuda S, Tamura M, Hayashi T, Takahashi T, Yamaguchi S. New standard of average size and weight of newborn in Japan. Jap J Pediat. 2010;114:1271–93.
World Health Organization. Internatilnal Stastical Classification of Diseases and Related Health Problems 10th Revison. 2016. https://apps.who.int/iris/handle/10665/246208. Accessed September 20 2021.
EUROCAT. EUROCAT Guide 1.5: EUROCAT Subgroups of Congenital Anomalies In: EUROCAT Central Registry. EUROCAT Central Registry. 2022. https://eu-rd-platform.jrc.ec.europa.eu/system/files/public/eurocat/Guide_1.5_Chapter_3.3_June_2022.pdf.
Ezoe K, Ni X, Kobayashi T, Kato K. Anti-Mullerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study. BMC Pregnancy Childbirth. 2020;20:740.
Zhang WY, von Versen-Hoynck F, Kapphahn KI, Fleischmann RR, Zhao Q, Baker VL. Maternal and neonatal outcomes associated with trophectoderm biopsy. Fertil Steril. 2019;112:283-290 e2.
Zheng W, Yang C, Yang S, Sun S, Mu M, Rao M, Zu R, Yan J, Ren B, Yang R, Guan Y. Obstetric and neonatal outcomes of pregnancies resulting from preimplantation genetic testing: a systematic review and meta-analysis. Hum Reprod Update. 2021;27:989–1012.
Makhijani R, Bartels CB, Godiwala P, Bartolucci A, DiLuigi A, Nulsen J, Grow D, Benadiva C, Engmann L. Impact of trophectoderm biopsy on obstetric and perinatal outcomes following frozen-thawed embryo transfer cycles. Hum Reprod. 2021;36:340–8.
Lu MM, Wen YX, Liu YL, Ding CH, Zhou CQ, Xu YW. Trophectoderm biopsy reduces the level of serum beta-human chorionic gonadotropin in early pregnancy. Fertil Steril. 2020;114:801–8.
Sites CK, Bachilova S, Gopal D, Cabral HJ, Coddington CC, Stern JE. Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer. Am J Obstet Gynecol. 2021;225(285):e1–7.
Swanson K, Huang D, Kaing A, Blat C, Rosenstein MG, Mok-Lin E, Gras J, Sperling JD. Is preimplantation genetic testing associated with increased risk of abnormal placentation after frozen embryo transfer? Am J Perinatol. 2021;38:105–10.
Li M, Kort J, Baker VL. Embryo biopsy and perinatal outcomes of singleton pregnancies: an analysis of 16,246 frozen embryo transfer cycles reported in the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. Am J Obstet Gynecol. 2021;224(500):e1–18.
Romundstad LB, Romundstad PR, Sunde A, von During V, Skjaerven R, Gunnell D, Vatten LJ. Effects of technology or maternal factors on perinatal outcome after assisted fertilisation: a population-based cohort study. Lancet. 2008;372:737–43.
He H, Jing S, Lu CF, Tan YQ, Luo KL, Zhang SP, Gong F, Lu GX, Lin G. Neonatal outcomes of live births after blastocyst biopsy in preimplantation genetic testing cycles: a follow-up of 1,721 children. Fertil Steril. 2019;112:82–8.
Kato K, Ueno S, Berntsen J, Kragh MF, Okimura T, Kuroda T. Does embryo categorization by existing artificial intelligence, morphokinetic or morphological embryo selection models correlate with blastocyst euploidy rates? Reprod Biomed Online. 2023;46:274–81.
Paulson RJ. Hidden in plain sight: the overstated benefits and underestimated losses of potential implantations associated with advertised PGT-A success rates. Hum Reprod. 2020;35:490–3.
Paulson RJ. Every last baby out of every last egg: the appropriate goal for fertility treatment in women older than 40 years. Fertil Steril. 2016;105:1443–4.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Contributions
Keiichi Kato and Kenji Ezoe contributed to the study design, data collection, interpretation writing and revision. Sachie Onogi, Shiho Ito, Rie Egawa, and Naoki Aoyama contributed to data collection. Tomoko Kuroda contributed to the data collection, interpretation, and manuscript revision. Akira Kuwahara, Takeshi Iwasa, Toshiyuki Takeshita, and Minoru Irahara contributed to manuscript revision. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
The study was approved by the Institutional Review Board of the Kato Ladies Clinic (approval numbers: 19–7, 19–9).
Consent to participate
Written informed consent for the retrospective analysis of de-identified data was obtained from patients undergoing in vitro fertilization treatment at the center.
Consent for publication
Not applicable.
Competing interests
The authors have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kato, K., Ezoe, K., Onogi, S. et al. Comparison of 1-year cumulative live birth and perinatal outcomes following single blastocyst transfer with or without preimplantation genetic testing for aneuploidy: a propensity score-matched study. J Assist Reprod Genet 40, 2669–2680 (2023). https://doi.org/10.1007/s10815-023-02926-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-023-02926-5